57939-04-5

• 常用中文名：1-(1H-吡唑-1-基)-2-丙胺
• 常用英文名：1-(1H-Pyrazol-1-yl)propan-2-amine
• CAS号：57939-04-5
• 分子式：C₆H₁₁N₃
• 分子量：125.17200
• 发布时间：2019-01-01 19:52:23
• 更新时间：2024-01-09 18:03:58

名称

• 中文名: 1-(1H-吡唑-1-基)-2-丙胺
• 英文名: 1-(1H-Pyrazol-1-yl)-2-propanamine
• 英文别名: 4-Methyl-3-nitro-benzoesaeure-methylester; 3-nitro-4-phenoxy-5-sulphamylbenzoic acid methyl ester; methyl 3-nitro-4-phenoxy-5-sulfamoylbenzoate; Methyl 3-nitro-p-toluate; Methyl 3-nitro-4-methylbenzoate; 3-nitro-4-phenoxy-5-sulfamoylbenzoic acid methyl ester; 4-Methyl-3-nitrobenzoic acid methyl ester

物化性质

• 分子式: C₆H₁₁N₃
• 分子量: 125.17200
• 精确质量: 125.09500
• PSA: 43.84000
• LogP: 0.93060

合成路线

67-56-1 28328-53-2 ~% 57939-04-5

文献：NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; Location in patent: Page/Page column 111 ; WO 2012/018635 A2

28328-53-2 18107-18-1 ~96% 57939-04-5

文献：CONCERT PHARMACEUTICALS INC.; Tung, Roger Patent: US2014/128469 A1, 2014 ; Location in patent: Paragraph 0110; 0112 ;

22892-96-2 ~% 57939-04-5

文献：NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2

108-95-2 ~% 57939-04-5

文献：NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2